09:45 AM EST - Pediapharm Inc. : Filed its second quarter financial results ended September 30, 2017. the Company achieved record quarterly revenue of $3,083,397 (compared to three-month period ended September 30, 2016 - $1,882,147), representing an increase of 64%. In the three-month period ended September 30, 2017, the Company achieved positive Adjusted EBITDA of $87,578 vs ($328, 282) in the three-month period ended September 30, 2016. This is the Company's first quarter with positive Adjusted EBITDA. Pediapharm Inc.
shares V.PDP are trading unchanged at $0.31.
